Cover Image
市場調查報告書

中國的Olanzapine市場分析

Investigation Report on China Olanzapine Market, 2010-2019

出版商 China Research and Intelligence 商品編碼 333629
出版日期 內容資訊 英文 25 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
中國的Olanzapine市場分析 Investigation Report on China Olanzapine Market, 2010-2019
出版日期: 2015年06月25日 內容資訊: 英文 25 Pages
簡介

Olanzapine自從打入中國市場之後便急速成長。年度銷售額從2005年的4,000萬人民幣,成長到2014年的4億2,000萬人民幣,年複合成長率達到30%。

本報告提供中國的Olanzapine市場相關調查分析,提供您市場規模,市場佔有率,零售價格,主要製造商,市場預測等相關的系統性資訊。

第1章 Olanzapine的相關概念

  • 適應
  • 全球市場銷售情形

第2章 中國的Olanzapine的市場簡介

  • 中國的Olanzapine的專利·核準情況
  • 主要製造商
  • 市場規模

第3章 中國的Olanzapine銷售情形分析

  • 銷售額
  • 銷售額數量

第4章 中國的Olanzapine主要廠商的市場佔有率分析

  • 市場佔有率:銷售額別
  • 市場佔有率:銷售量別

第5章 中國的Olanzapine的各劑型分析

  • 市場佔有率 (各劑型) :銷售額別
  • 市場佔有率 (各劑型) :銷售量別

第6章 中國的Olanzapine的醫院用標準價格

  • Changzhou Watson Pharmaceuticals Co., Ltd
  • Hanson Pharmaceutical
  • Eli Lilly and Company (美國)
  • Eli Lilly and Company (英國)

第7章 中國的Olanzapine市場主要製造商

  • Changzhou Watson Pharmaceuticals Co., Ltd
  • Hanson Pharmaceutical
  • Eli Lilly and Company (美國)

第8章 中國的Olanzapine市場預測

  • 市場規模的預測
  • 競爭情形的預測

圖表

目錄
Product Code: 1506234

According to WHO's statistics, at least 10% of world population suffer from various kinds of mental illnesses. According to the statistics published by the National Center for Mental Health, China-CDC, the number of cases of mental illnesses is more than 100 million, among which 16 million suffer from holergasia. Mental illness has surpassed cancer and become the biggest threat to human health, ranking first in the total burden of disease in China.

As an atypical antipsychotic, olanzapine is mainly used for the treatment of the positive symtoms of schizophrenia and it also has some curative effects on schizophrenia's negative symtoms. Developed on the base of clozapine, the former generation of antipsychotic medication, olanzapine was approved by Food and Drug Administration (FDA) to go on sale in 1996 and its patent held by Eli Lilly expired in 2011. The preparations of olanzapine available in mainland China include domestic Oulaining, Ximin and imported Zyperxa.

As a drug for schizophrenia, olanzapine entered the European and American market in 1996 and then the Chinese market in 1999. In 2003, it was even rated as the first-line drug in the Guidelines for Prevention and Control of Schizophrenia. Olanzapine develops fast after entering China, annual sales value rising from less than CNY 40 million in 2005 to CNY 420 million in 2014 and CAGR during this period reaching 30%. Hanson Pharmaceutical, Changzhou Watson Pharmaceuticals Co., Ltd and Eli Lilly and Company occupy the major market share, among which Hanson Pharmaceutical has the largest market share of about 44% for sales value in 2014.

With the change of life styles and the increased stress in work and life brought about by China's economic development, the incidence of mental illness and psychological problems is growing. Therefore, the market size of olanzapine in China is expected to keep expanding in the next few years.

Readers can get at least the following information from this report:

  • market size of olanzapine in China
  • competitive landscape of olanzapine in Chinese market
  • price of olanzapine made by different enterprises in China
  • market outlook of olanzapine in China

The author suggests the following groups of people purchase this report:

  • manufacturers of antipsychotics
  • investors/ research institutions interested in Chinese medicine market
  • any interest in the Chinese medicine market, please contact CRI for customized survey service

Table of Contents

1. Related Concepts of Olanzapine

  • 1.1. Indication
  • 1.2. Sales Status in Global Market

2. Market Profile of Olanzapine in China

  • 2.1. Patent and Approval Status of Olanzapine in China
  • 2.2. Major Manufacturers
  • 2.3. Market Size

3. Survey on Sales Status of Olanzapine in China, 2010-2014

  • 3.1. Sales Value
    • 3.1.1. Overall Sales Value
    • 3.1.2. Sales Value by Regions
  • 3.2. Sales Volume
    • 3.2.1. Overall Sales Volume
    • 3.2.2. Sales Volume by Regions

4. Survey on Market Share of Major Manufacturers of Olanzapine in China, 2010-2014

  • 4.1. Market Share by Sales Value
  • 4.2. Market Share by Sales Volume

5. Survey on Dosage Forms of Olanzapine in China, 2010-2014

  • 5.1. Share of Different Dosage Forms by Sales Value
  • 5.2. Share of Different Dosage Forms by Sales Volume

6. Reference Price of Olanzapine in Chinese Hospitals in 2014

  • 6.1. Changzhou Watson Pharmaceuticals Co., Ltd (Trade Name: Ximin)
  • 6.2. Hanson Pharmaceutical (Trade Name: Oulanning)
  • 6.3. Eli Lilly and Company (US) (Trade Name: Zyprexa)
  • 6.4. Eli Lilly and Company (UK) (Trade Name: Zyprexa)

7. Major Manufacturers of Olanzapine in Chinese Market, 2010-2014

  • 7.1. Changzhou Watson Pharmaceuticals Co., Ltd
  • 7.2. Hanson Pharmaceutical
  • 7.3. Eli Lilly and Company (US)

8. Market Outlook of Olanzapine in China, 2015-2019

  • 8.1. Forecast of Market Size
  • 8.2. Forecast of Competitive Landscape

Table of Selected Charts

  • Chart Patent Status of Olanzapine in China
  • Chart Approval Information of Olanzapine in China
  • Chart Sales Status of Olanzapine in China, 2010-2014
  • Chart Sales Value of Olanzapine in China, 2010-2014
  • Chart Sales Value of Olanzapine in Some Regions in China, 2010-2014
  • Chart Sales Volume of Olanzapine in China, 2010-2014
  • Chart Sales Value and Market Share of Olanzapine Made by Hanson in China, 2010-2014
  • Chart Sales Value and Market Share of Olanzapine Made by Eli Lilly and Company (UK) in China, 2010-2014
  • Chart Sales Value and Market Share of Olanzapine Made by Eli Lilly and Company (US) in China, 2010-2014
  • Chart Sales Value and Market Share of Olanzapine Made by Changzhou Watson in China, 2010-2014
  • Chart Price of Olanzapine Made by Changzhou Watson Pharmaceuticals Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Olanzapine Made by Hanson in Some Chinese Cities in 2014
  • Chart Price of Olanzapine Made by Eli Lilly and Company (US) in Some Chinese Cities in 2014
  • Chart Price of Olanzapine Made by Eli Lilly and Company (UK) in Some Chinese Cities in 2014
Back to Top